Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1392 of 2842 -
Monday, February 09 2026 | 02:26:42 PM

Rise Gold Grants Stock Options

Grass Valley, California–(Newsfile Corp. – May 22, 2025) – Rise Gold Corp. (CSE: RISE) (OTCQB: RYES) (the “Company” or “Rise Gold”) announces that it has granted a total of 3,320,000 stock options to directors, officers, and consultants of the Company pursuant to the terms of the Company’s Stock Option Plan. …

Read More »

Prospector Announces Final Closing of its Non-Brokered Private Placement to Fund Drilling on the ML Project, Yukon

Vancouver, British Columbia–(Newsfile Corp. – May 22, 2025) – Prospector Metals Corp. (TSXV: PPP) (OTCQB: PMCOF) (FSE: 1ET) (“Prospector” or the “Company”) announces the final closing of its non-brokered private placement raising total gross proceeds to the Company of C$5,735,350 (the “Offering”). The second tranche of the Offering consisted of …

Read More »

Generic Gold Announces Resignation of Director

Toronto, Canada–(Newsfile Corp. – May 22, 2025) – Generic Gold Corp. (CSE: GGC) (FSE: 1WD) (OTC Pink: GGCPF) (“Generic Gold” or the “Company”) announces the resignation of Mr. Bernard Dionne as a director of the Company, effective immediately. The Company would like to thank Mr. Dionne for his contributions to …

Read More »

Inomin Announces Non-Brokered Private Placement

Vancouver, British Columbia–(Newsfile Corp. – May 22, 2025) – Inomin Mines Inc. (TSXV: MINE) (“Inomin” or the “Company”) announces a non-brokered private placement of securities to raise total gross proceeds up to $200,000 (the “Financing”). The Financing will be comprised of non-flow-through units (the “NFT Units”) to be sold at …

Read More »

Sharp Therapeutics Corp. Reports First Quarter 2025 Results

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – May 22, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a pre-clinical-stage biotechnology company developing small molecule therapies to treat genetic diseases, announces the release of its condensed interim consolidated financial statements for the three months ended March 31, 2025, …

Read More »